CompletedNot applicableNCT05523180

A Study to Evaluate the Effect of Probiotic Supplement on Quality of Life

Studying Cystic fibrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
ResBiotic Nutrition, Inc.
Principal Investigator
Anthony Bier, MD
Nutrasource Pharmaceutical and Nutraceutical Services
Intervention
Probiotic(dietary_supplement)
Enrollment
37 enrolled
Eligibility
18-80 years · All sexes
Timeline
20222023

Study locations (2)

Collaborators

Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05523180 on ClinicalTrials.gov

Other trials for Cystic fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Cystic fibrosis

← Back to all trials